Inside the Mind of Deserusan

After my last sponsored supplement review I have certainly taken notice to beta-alanine and those who market it. Recently, I came across some presentations from the International Society of Sports Nutrition (ISSN) conference from this past year which utilized a beta-alanine supplement Carnosyn. I was impressed by the following posters:
Harris RC1, Ponte J1, Hill CA1, Sale C1, Jones GA1, Kim HJ2), Wise JA3 Effect of 14 and 28 days Ÿ-Alanine (Carnosyn©) supplementation on isometric endurance of the knee extensors. 1University of Chichester, Chichester, UK; 2Korea National Sport University, Seoul, Korea; 3Natural Alternatives International, San Marcos, USA
Kendrick I1, Harris RC1, Kim CK2, Kim HJ2, Viet DH3, Thanh LQ3, Toai, BT3, Wise JA4 The effect of Ÿ-alanine (Carnosyn©) supplementation on muscle carnosine synthesis during 4 weeks using a one-leg training model. 1University of Chichester, UK; 2Korea National Sport University, Korea; 3University of Physical Education and Sport II, Vietnam; 4Natural Alternatives Intl, San Marcos, USA
Kendrick I1, Kim CK2, Viet DH3, Harris RC1, Kim HJ2,Thanh LQ3, Toai, BT3, Wise JA4 The effect of Ÿ-alanine (Carnosyn©) supplementation on muscle carnosine synthesis during a 10 week program of strength training. 1University of Chichester, Chichester, UK; 2Korea National Sport University, Seoul, Korea; 3University of Physical Education and Sport II, Hochiminh City, Vietnam; 4Natural Alternatives Intl, San Marcos, USA
Kim HJ1, Kim CK1, Lee YW1, Harris RC2, Sale C2, Harris DB2, Wise JA3 The effect of a supplement containing Ÿ-alanine on muscle carnosine synthesis and exercise capacity, during 12 wk combined endurance and weight training. 1Korea National Sport University, Seoul, Korea; 2University of Chichester, Chichester, UK; 3Natural Alternatives Intl, San Marcos, USA
It’s nice to see research studies performed on actual supplements. I truly feel this approach to supplementation will legitimize the industry a lot more in the eyes of those in the national press who only focus on the negatives.
More importantly, I’m glad to see the company who makes Carnosyn, Natural Alternatives International, Inc of San Marcos, California is doing quite well. Here was a recent press release from them:
Natural Alternatives International, Inc. Announces 15% Increase in First Quarter Revenue
Monday October 23, 8:50 am ET
SAN MARCOS, Calif., Oct. 23 /PRNewswire-FirstCall/ — Natural Alternatives International, Inc. (”NAI”) (Nasdaq: NAII - News), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced a 15% increase in revenue to $25.2 million and net income of $387,000 or $0.05 per diluted share for the three months ended September 30, 2006.
First quarter revenue increased 15% to $25.2 million from $21.9 million for the comparable quarter last year. Income from operations improved by 23% to $832,000 compared to $678,000 in the comparable quarter last year. Net income decreased to $387,000 or $0.05 per diluted share from $412,000 or $0.06 per diluted share for the comparable quarter last year.
Cash flows from operating activities for the first quarter were $7.7 million. As of September 30, 2006, NAI had cash and working capital of $2.0 million and $14.0 million, respectively, compared to $2.2 million and $13.2 million, respectively, as of June 30, 2006. As of September 30, 2006, we had $5.4 million available under our working capital line of credit.
President Randell Weaver stated, “We are pleased to see 15% growth in revenue resulting from $1.1 million of additional contract manufacturing sales along with an increase in revenue from branded products resulting primarily from our acquisition of Real Health Laboratories (RHL). In connection with our revenue growth, we experienced solid growth in operating income. Our growth in operating income in the first quarter was offset by additional interest expense, relating to the acquisition of RHL and carrying costs of accounts receivable and inventory for a new contract manufacturing relationship, which led to a slight decline in net income and earnings per share compared to last year’s first quarter. We anticipate revenue in the second quarter of fiscal 2007 will exceed revenue from the second quarter of the prior year primarily due to higher revenue from branded products. Overall, we expect our trend of annual revenue growth will continue.”
CEO Mark LeDoux added, “During the first quarter we completed the integration of previously outsourced call center activities for our Dr. Cherry Pathway to Healing® product line into RHL’s existing operation. The cost savings resulting from the integration of previously outsourced activities will be invested in expanding and marketing our branded products. We continue to focus on increasing shareholder value through long-term growth while maintaining steady profitability.”
NAI, headquartered in San Marcos, California, is a leading formulator, manufacturer and marketer of nutritional supplements and provides strategic partnering services to its customers. Our comprehensive partnership approach offers a wide range of innovative nutritional products and services to our clients including: scientific research, clinical studies, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, regulatory review and international product registration assistance. For more information about NAI, please see our website at www.nai-online.com.
This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 that are not historical facts and information. These statements represent our intentions, expectations and beliefs concerning future events, including, among other things, our expectations and beliefs with respect to future financial and operating results, including the amount of our future revenue and profits, our ability to successfully integrate RHL’s operations within specified time periods and the impact on profitability of such integration, our ability to realize strategic, operational and financial benefits from the acquisition and integration of RHL, to continue to implement our strategic plans, to expand and successfully market our brands, and to develop, maintain or increase sales to new and existing customers. We wish to caution readers these statements involve risks and uncertainties that could cause actual results and outcomes for future periods to differ materially from any forward-looking statement or views expressed herein. NAI’s financial performance and the forward-looking statements contained herein are further qualified by other risks including those set forth from time to time in the documents filed by us with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q.

This entry was posted on Tuesday, October 31st, 2006 at 7:27 pm and is filed under Rants. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.